Technische Universität München (TUM)

Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value and Association to Postoperative Infarct Volume (2018) Bette S, Barz M, Huber T, Straube C, Schmidt-Graf F, Combs SE, Delbridge C, et al. Journal article Dosimetric characterization of a single crystal diamond detector in X-ray beams for preclinical research Dosimetrische Charakterisierung eines Einkristall-Diamant-Detektors in Röntgenstrahlen zur präklinischen Forschung (2018) Kampfer S, Cho N, Combs SE, Wilkens JJ Journal article Moving second courses of radiotherapy forward: Early re-irradiation after surgical resection for recurrent gliomas improves efficacy with excellent tolerability (2018) Combs SE, Kessel KA, Hesse J, Straube C, Zimmer C, Schmidt-Graf F, Schlegel J, et al. Journal article Concepts and terms for dose/volume parameters in carbon-ion radiotherapy: Conclusions of the ULICE taskforce Concepts et terminologie des paramètres de dose et volumes proposés en hadronthérapie par ions carbone (2018) Vogin G, Wambersie A, Poetter R, Beuve M, Combs SE, Magrin G, Mayer R, et al. Journal article Dual-layer spectral computed tomography: measuring relative electron density (2018) Mei K, Ehn S, Oechsner M, Kopp FK, Pfeiffer D, Fingerle AA, Pfeiffer F, et al. Journal article Common and distinct changes of default mode and salience network in schizophrenia and major depression (2018) Shao J, Meng C, Tahmasian M, Brandl F, Yang Q, Luo G, Luo C, et al. Journal article Shaping the digital transformation of laboratory medicine (2018) Bietenbeck A, Ganslandt T Journal article ForensicTransfer: Weakly-supervised Domain Adaptation for Forgery Detection (2018) Cozzolino D, Thies J, Roessler A, Riess C, Niessner M, Verdoliva L Other publication type Secretin-Activated Brown Fat Mediates Prandial Thermogenesis to Induce Satiation (2018) Li Y, Schnabl K, Gabler SM, Willershaeuser M, Reber J, Karlas A, Laurila S, et al. Journal article MOR202 with Low-Dose Dexamethasone (Dex) or Pomalidomide/Dex or Lenalidomide/Dex in Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis of a Phase I/IIa, Multicenter, Dose-Escalation Study (2018) Raab MS, Chatterjee M, Goldschmidt H, Agis H, Blau I, Einsele H, Engelhardt M, et al. Conference contribution